# Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention

> **NCT06820086** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Mikk JÜRISSON** · enrollment: 2714 (actual)

## Conditions studied

- PRS-based Primary Prevention of CVD

## Interventions

- **DRUG:** Rosuvastatin 20mg

## Key facts

- **NCT ID:** NCT06820086
- **Lead sponsor:** Mikk JÜRISSON
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2031-03
- **Final completion:** 2034-03
- **Target enrollment:** 2714 (ACTUAL)
- **Last updated:** 2026-05-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820086, "Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT06820086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*